Показано 0 из 0
Дата |
---|
15.06.2023 |
14.06.2023 |
12.05.2023 |
11.05.2023 |
10.05.2023 |
09.05.2023 |
08.05.2023 |
05.05.2023 |
04.05.2023 |
03.05.2023 |
Bid | Ask |
Open |
Min | Max |
Last |
Legal close |
Avg |
Оборот |
Кол-во сделок |
---|---|---|---|---|---|---|---|
|
|
0.014
|
0.01
|
0.014
|
0.01
|
|
|
375.00
|
3.00
|
|
|
0.014
|
0.014
|
0.014
|
0.014
|
|
|
175.70
|
2.00
|
|
|
|
|
|
0.37
|
|
|
|
|
|
|
|
|
|
0.37
|
|
|
|
|
|
|
|
|
|
0.37
|
|
|
|
|
|
|
|
|
|
0.37
|
|
|
|
|
|
|
|
|
|
0.37
|
|
|
|
|
|
|
|
|
|
0.37
|
|
|
|
|
|
|
|
|
|
0.37
|
|
|
|
|
|
|
|
|
|
0.37
|
|
|
|
|
BenevolentAI is a leading, clinical-stage AI drug discovery company. Through the combined capabilities of its AI platform, scientific expertise and wet-lab facilities, BenevolentAI is well-positioned to deliver novel drug candidates with a higher probability of clinical success than those developed using traditional methods.